Czechia, Sept. 23 -- Czechia based Novartis s.r.o. has secured contract from Masarykuv onkologicky ustav for Pharmaceutical products - Lutecium-177 vipivotid tetraxetan [2025]. The value of the contract is worth 12363605000 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....